- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/46 - Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Patent holdings for IPC class C07D 211/46
Total number of patents in this class: 567
10-year publication summary
|
48
|
42
|
34
|
30
|
38
|
36
|
30
|
22
|
30
|
12
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amicus Therapeutics, Inc. | 352 |
19 |
| FUJIFILM Corporation | 30340 |
17 |
| Taisho Pharmaceutical Co., Ltd. | 856 |
12 |
| Theravance Biopharma R&D IP, LLC | 414 |
11 |
| Novartis AG | 10336 |
9 |
| Recurium IP Holdings, LLC | 126 |
9 |
| Takeda Pharmaceutical Company Limited | 2713 |
8 |
| Alectos Therapeutics Inc. | 45 |
8 |
| Bristol-myers Squibb Company | 4774 |
6 |
| Centre National de La Recherche Scientifique | 10922 |
6 |
| Daiichi Sankyo Company, Limited | 1892 |
6 |
| Otsuka Pharmaceutical Co., Ltd. | 1502 |
6 |
| Gen1e Lifesciences Inc. | 30 |
6 |
| AstraZeneca AB | 2830 |
5 |
| JSR Corporation | 2528 |
5 |
| Astellas Pharma Inc. | 1034 |
5 |
| BioMarin Pharmaceutical Inc. | 401 |
5 |
| Lexicon Pharmaceuticals, Inc. | 189 |
5 |
| OP Bio Factory Co., Ltd. | 14 |
5 |
| Pfizer Limited | 152 |
5 |
| Other owners | 409 |